• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

秋水仙碱在心血管疾病中的应用:一项系统评价。

The Use of Colchicine in Cardiovascular Diseases: A Systematic Review.

作者信息

Siak Jessica, Flint Nir, Shmueli Hezzy G, Siegel Robert J, Rader Florian

机构信息

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif.

Department of Cardiology, Tel Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Israel.

出版信息

Am J Med. 2021 Jun;134(6):735-744.e1. doi: 10.1016/j.amjmed.2021.01.019. Epub 2021 Feb 17.

DOI:10.1016/j.amjmed.2021.01.019
PMID:33609528
Abstract

The medicinal properties of colchicine have been recognized for centuries. Although previously used for gout and familial Mediterranean fever, its immune-modulating, anti-inflammatory, and antifibrotic effects are increasingly recognized as beneficial in the treatment of cardiovascular disorders. In this systematic review, we summarize the current evidence on colchicine's effectiveness in 1) pericarditis, 2) coronary artery disease, and 3) atrial fibrillation. We also discuss the safety, potential adverse effects, and common drug interactions that should be considered during use.

摘要

几个世纪以来,秋水仙碱的药用特性已为人所知。尽管它以前用于治疗痛风和家族性地中海热,但其免疫调节、抗炎和抗纤维化作用在心血管疾病治疗中的益处日益得到认可。在本系统评价中,我们总结了关于秋水仙碱在以下方面有效性的现有证据:1)心包炎,2)冠状动脉疾病,3)心房颤动。我们还讨论了使用过程中应考虑的安全性、潜在不良反应和常见药物相互作用。

相似文献

1
The Use of Colchicine in Cardiovascular Diseases: A Systematic Review.秋水仙碱在心血管疾病中的应用:一项系统评价。
Am J Med. 2021 Jun;134(6):735-744.e1. doi: 10.1016/j.amjmed.2021.01.019. Epub 2021 Feb 17.
2
Colchicine in Cardiovascular Disease: In-Depth Review.秋水仙碱在心血管疾病中的应用:深入综述。
Circulation. 2022 Jan 4;145(1):61-78. doi: 10.1161/CIRCULATIONAHA.121.056171. Epub 2021 Dec 29.
3
Colchicine for cardiovascular medicine: a systematic review and meta-analysis.秋水仙碱在心血管医学中的应用:系统评价和荟萃分析。
Future Cardiol. 2022 Aug;18(8):647-659. doi: 10.2217/fca-2020-0206. Epub 2022 Jul 5.
4
Effect of colchicine in prevention of pericardial effusion and atrial fibrillation: a meta-analysis.秋水仙碱预防心包积液和心房颤动的效果:一项荟萃分析。
Intern Emerg Med. 2016 Sep;11(6):867-76. doi: 10.1007/s11739-016-1496-5. Epub 2016 Jul 4.
5
Isolating Colchicine in 19th Century: An Old Drug Revisited.19 世纪的秋水仙素提取:一种被重新审视的老药。
Curr Pharm Des. 2018;24(6):654-658. doi: 10.2174/1381612824666180115105850.
6
Repurposing Colchicine for Heart Disease.将秋水仙碱用于治疗心脏病(药物用途拓展)
Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:121-129. doi: 10.1146/annurev-pharmtox-052120-020445. Epub 2021 Sep 30.
7
Colchicine and the heart: pushing the envelope.秋水仙碱与心脏:开拓新领域。
J Am Coll Cardiol. 2013 Nov 12;62(20):1817-25. doi: 10.1016/j.jacc.2013.08.726. Epub 2013 Sep 11.
8
Colchicine's Role in Cardiovascular Disease Management.秋水仙碱在心血管疾病管理中的作用。
Arterioscler Thromb Vasc Biol. 2024 May;44(5):1031-1041. doi: 10.1161/ATVBAHA.124.319851. Epub 2024 Mar 21.
9
Colchicine: an old wine in a new bottle?秋水仙碱:旧瓶装新酒?
Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):14-23. doi: 10.2174/1871523011312010004.
10
The Role of Colchicine in Pericardial Syndromes.秋水仙碱在心包综合征中的作用。
Curr Pharm Des. 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823.

引用本文的文献

1
Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature.不同病因相关的继发性心包积液的发病率:文献综述
J Cardiothorac Surg. 2025 Feb 22;20(1):141. doi: 10.1186/s13019-025-03370-5.
2
Colchicine for the primary prevention of cardiovascular events.秋水仙碱用于心血管事件的一级预防。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD015003. doi: 10.1002/14651858.CD015003.pub2.
3
Rhabdomyolysis associated with concomitant use of colchicine and statins in the real world: identifying the likelihood of drug-drug interactions through the FDA adverse event reporting system.
现实世界中与秋水仙碱和他汀类药物联合使用相关的横纹肌溶解症:通过美国食品药品监督管理局不良事件报告系统确定药物相互作用的可能性。
Front Pharmacol. 2024 Sep 16;15:1445324. doi: 10.3389/fphar.2024.1445324. eCollection 2024.
4
Salicylic acid modulates secondary metabolism and enhanced colchicine accumulation in long yellow daylily ().水杨酸调节长黄花萱草的次生代谢并增强秋水仙碱积累。
AoB Plants. 2024 May 21;16(4):plae029. doi: 10.1093/aobpla/plae029. eCollection 2024 Jul.
5
Suspected colchicine-induced late myocardial rupture occurring after the late presentation of acute inferior ST-elevation myocardial infarction.疑似秋水仙碱诱发的晚期心肌破裂,发生于急性下壁ST段抬高型心肌梗死延迟就诊之后。
Am J Cardiovasc Dis. 2024 Apr 15;14(2):116-120. doi: 10.62347/FXLN8938. eCollection 2024.
6
Time to benefit of colchicine in patients with cardiovascular disease: A pooled analysis of randomized controlled trials.秋水仙碱对心血管疾病患者的获益时间:随机对照试验的汇总分析
Heliyon. 2024 Apr 29;10(9):e30408. doi: 10.1016/j.heliyon.2024.e30408. eCollection 2024 May 15.
7
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.重新审视循环细胞外基质片段作为骨髓纤维化及相关肿瘤的疾病标志物
Cancers (Basel). 2023 Aug 29;15(17):4323. doi: 10.3390/cancers15174323.
8
Novel Potential Targets for Function-Promoting Therapies: Orphan Nuclear Receptors, Anti-inflammatory Drugs, Troponin Activators, Mas Receptor Agonists, and Urolithin A.促进功能治疗的新型潜在靶点:孤儿核受体、抗炎药物、肌钙蛋白激活剂、Mas 受体激动剂和尿石素 A。
J Gerontol A Biol Sci Med Sci. 2023 Jun 16;78(Suppl 1):44-52. doi: 10.1093/gerona/glad072.
9
A Systematic Review of COVID-19 and Pericarditis.新型冠状病毒肺炎与心包炎的系统评价
Cureus. 2022 Aug 12;14(8):e27948. doi: 10.7759/cureus.27948. eCollection 2022 Aug.
10
Efficacy and Safety of Colchicine in Prevention of Secondary Cardiovascular Outcomes Among Patients With Coronary Vessel Disease: A Meta-Analysis.秋水仙碱预防冠心病患者继发性心血管结局的疗效与安全性:一项荟萃分析
Cureus. 2022 Jul 9;14(7):e26680. doi: 10.7759/cureus.26680. eCollection 2022 Jul.